Brazil · Delayed Price · Currency is BRL Boa Safra Sementes Earnings Call Transcripts
Fiscal Year 2026
-
Net operating revenue rose 23% and gross profit 83% year-over-year, driven by new crops and diversification. Order backlog hit a record BRL 1.8 billion, while efficiency gains improved margins and reduced net debt. Margin recovery and growth in new crops are expected in the second half.
-
First quarter saw revenue growth and strong liquidity, despite lower profits due to market pressures and excess inventory. Efficiency projects and diversification are expected to restore margins and drive growth, with seed shortages supporting higher prices.
Fiscal Year 2025
-
Record seed sales and expanded national presence marked 2025, despite sector headwinds and lower margins. Focus for 2026 shifts to margin recovery, operational efficiency, and maximizing installed capacity, supported by a strong capital structure and strategic partnerships.
-
Record sales and market share gains were achieved despite margin pressure and challenging agribusiness conditions. Strong liquidity, a robust order backlog, and diversified growth position the company for a strong Q4 and improved profitability in 2026.
-
Operational and financial growth marked the first half of 2025, with net revenue up 43% and gross margin rising to 47%. Advanced payments and a diversified portfolio improved working capital, while CapEx was reduced in favor of asset-light expansion.
-
Q1 2025 saw a 90% revenue increase and a return to profitability, driven by seed sales and diversification. Operational cash flow and order backlog improved, with expansion into new regions and a focus on technology and risk management supporting a positive outlook.
Fiscal Year 2024
-
2024 results were significantly impacted by severe weather, leading to lower production, revenue, and profit. Despite these setbacks, investments in new technologies, distribution, and regenerative agriculture, along with a strong capital structure, position the company for a 40% sales volume growth and margin recovery in 2025.
-
Q2 2024 saw strong revenue diversification and a BRL 300 million capital raise to fund expansion, with adjusted EBITDA up 58% year-over-year. Despite seasonal revenue softness and high net debt, outlook remains positive for H2 2024 and 2025, driven by new capacity and technology.